Reelin signalling in neuroblastoma: Migratory switch in metastatic stages

  • Authors:
    • Jürgen Becker
    • Johanna Fröhlich
    • Christina Perske
    • Helena Pavlakovic
    • Jörg Wilting
  • View Affiliations

  • Published online on: May 18, 2012     https://doi.org/10.3892/ijo.2012.1488
  • Pages: 681-689
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The essential functions of Reelin for the migratory behaviour of neuroblasts in the central nervous system are well documented. Its role in the dissemination of neuronal tumours of the peripheral nervous system has not been studied in detail. Here, we examined neuroblastoma (NB), a tumour derived from sympathoadrenal cells of neural crest origin. We studied the expression of Reelin, its receptors VLDLR and LRP8 and the adapter protein DAB1 in primary tumour samples and cell lines. We used real-time RT-PCR, immunohistology and western blot analysis. In NB cell lines we studied effects of all-trans retinoic acid and the in vitro effects of Reelin. In primary tumour samples of untreated patients, a significant downregulation of Reelin and DAB1 mRNA was found in the metastatic stages 3, 4 and 4s. Immunohistochemical studies revealed expression of Reelin, LRP8 and DAB1 in differentiating-type low-grade NB. In vitro, western blot analysis of selected NB cell lines showed variable expression patterns. Differentiation induction with all-trans retinoic acid induced the upregulation of Reelin and DAB1. Reelin acted as a chemoattractant for various NB cell lines but inhibited migration when applied together with the NB cells. In normal tissue, we found Reelin in lymphatic endothelial cells (LECs) but not in blood vessel endothelium (BECs). In primary NB, both BECs and LECs were positive. Our data strongly suggest that Reelin has a dual role in NB. Autocrine expression marks low-grade differentiating tumour cells, whereas paracrine Reelin presented by LECs and BECs may act as a chemoattractant and promote hematogenic and lymphogenic dissemination in progressed stages.
View Figures
View References

Related Articles

Journal Cover

August 2012
Volume 41 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Becker J, Fröhlich J, Perske C, Pavlakovic H and Wilting J: Reelin signalling in neuroblastoma: Migratory switch in metastatic stages. Int J Oncol 41: 681-689, 2012
APA
Becker, J., Fröhlich, J., Perske, C., Pavlakovic, H., & Wilting, J. (2012). Reelin signalling in neuroblastoma: Migratory switch in metastatic stages. International Journal of Oncology, 41, 681-689. https://doi.org/10.3892/ijo.2012.1488
MLA
Becker, J., Fröhlich, J., Perske, C., Pavlakovic, H., Wilting, J."Reelin signalling in neuroblastoma: Migratory switch in metastatic stages". International Journal of Oncology 41.2 (2012): 681-689.
Chicago
Becker, J., Fröhlich, J., Perske, C., Pavlakovic, H., Wilting, J."Reelin signalling in neuroblastoma: Migratory switch in metastatic stages". International Journal of Oncology 41, no. 2 (2012): 681-689. https://doi.org/10.3892/ijo.2012.1488